# Ivy Venture Group

> Ivy Venture Group is a VC fund backing Health Care, Therapeutics and Biotechnology. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 2
- Last investment: Jun 2024
- Lead investor: 0%
- Last updated: Aug 2026

Ivy Venture Group is a venture capital firm.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 50% |
| Therapeutics | 1 | 50% |
| Biotechnology | 1 | 50% |
| Social Impact | 1 | 50% |
| Pharmaceutical | 1 | 50% |

6 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 50% |
| Pre-Seed | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| rediem | Ripplfect is creating a platform for sustainable habit rewards to assist society in combating pollution and climate change. Our technologically advanced platform connects environmentally conscious individuals, businesses, and nonprofits. Ripplfect converts your environmentally conscious purchases and actions into points, cashback, and donations. | $1.2M | Pre-Seed | Jun 20, 2024 |  |
| Fuse Biotherapeutics | Fuse Biotherapeutics is a biotech company developing next-generation immune-modulating therapeutics for patients with cancers. The company's therapeutic approach integrates the multiple steps of an immune response in a rational manner such that potent responses to danger are targeted without sacrificing natural breaks in the system that sparehealthy tissues.Fuse Biotherapeutics was founded in 2021 and is headquartered in Los Angeles, CA. | $9.5M | Seed | Nov 15, 2021 |  |

2 of 2 investments shown.

## Co-investors
- [(ERA) Entrepreneurs Roundtable Accelerator](https://shizune.co/investors/profile/er-accelerator) — VC Fund, 1 deal together
- [GC&H Investments](https://shizune.co/investors/profile/gc-h-investments) — VC Fund, 1 deal together
- [Ivy Ventures](https://shizune.co/investors/profile/ivy-ventures-984e) — VC Fund, 1 deal together
- [Sherpa Healthcare Partners](https://shizune.co/investors/profile/sherpa-venture-capital) — VC Fund, 1 deal together
- [Sirona Capital](https://shizune.co/investors/profile/sirona-capital) — VC Fund, 1 deal together
- [Viva BioInnovator](https://shizune.co/investors/profile/viva-biotech) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Ivy Venture Group invest in?

Ivy Venture Group invests primarily in Health Care, Therapeutics and Biotechnology startups, most often at Seed and Pre-Seed stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Ivy Venture Group last invest?

The most recent investment recorded for Ivy Venture Group closed in Jun 2024. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co